Bank Of New York Mellon Corp Biora Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.13 - $12.03 $7,339 - $679,153	56,455 New	56,455 $7,000
Q4 2021 Feb 11, 2022	BUY	$1.35 - $4.89 $57,261 - $207,414	42,416 Added 302.13%	56,455 $118,000
Q2 2021 Aug 11, 2021	SELL	$2.11 - $4.93 $56,140 - $131,172	-26,607 Reduced 65.46%	14,039 $50,000
Q1 2021 May 13, 2021	BUY	$3.91 - $7.31 $93,140 - $174,131	23,821 Added 141.58%	40,646 $193,000
Q4 2020 Feb 09, 2021	BUY	$3.27 - $9.48 $55,017 - $159,501	16,825 New	16,825 $89,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.